United States Air Force (US Air Force) veteran Ralph Thurman spent more than two decades as an active duty and reserves fighter pilot. He won military decorations such as the Distinguished Flying Cross, Viet Nam Cross of Gallantry and eight Air Medals,. He earned induction into the Distinguished Flying Cross Society. He also is a graduate of US Air Force Survival, Evasion, Resistance and Escape School and US Air Force Command and Staff College, Ralph Thurman also became an instructor pilot in advanced jet fighter aircraft.
In addition to being a decorated veteran, Ralph Thurman is an experienced healthcare executive and private equity leader. He joined Rhone-Poulenc Rorer Pharmaceuticals, Inc., (now Aventis) in 1984 and was promoted to group president four years later. After his departure, he became the chairman and CEO at Corning Life Sciences. During his five years in this role, he developed the industry’s first genomics testing lab and developed the strategy leading to the creation of New York Stock Exchange companies Covance and Quest Diagnostics.
Ralph Thurman founded VIASYS Healthcare, Inc., in 1999 by consolidating nearly two dozen businesses into four strategic business units. He led the medical technology company to become the global leader in respiratory diagnostics and neurodiagnostics and developed its international business, which accounted for 40 percent of its total revenue. In 2007, he sold the firm, and he has since been involved with numerous companies in roles as chairman, director and operating advisor. The companies include Cardionet Inc (now Biotelemetry), Cogent HMG, Avantor, Nusil, TFF Pharmaceuticals and Outlook Therapeutics. He also has taught a postgraduate program in financial leadership at Merrimack College.